Aileron Therapeutics Inc (ALRN)
NASDAQ
The current ALRN market cap is 61.96M. The company's latest EPS is USD -0.7261 and P/E is -3.94.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.99M | -1.98M | -7.29M | -7.21M | -9.04M |
Net Income | -1.79M | -1.83M | -7.34M | -7.11M | -8.94M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -29.96M | -20.5M | -26.61M | -27.65M | -16.28M |
Net Income | -29.37M | -21.16M | -26.16M | -27.33M | -15.73M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.99M | 12.82M | 106.01M | 99.19M | 109.4M |
Total Liabilities | 1.2M | 1.62M | 7.71M | 7.86M | 8.38M |
Total Equity | 12.79M | 11.2M | 98.3M | 44.75M | 56.02M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 26.47M | 16.34M | 48.48M | 22.01M | 106.01M |
Total Liabilities | 10.43M | 4.18M | 4.58M | 3.38M | 7.71M |
Total Equity | 16.05M | 12.16M | 43.9M | 18.62M | 98.3M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.78M | -9.42M | -19.81M | -5.27M | -13.66M |
Investing | 15.75M | 16.29M | 16.2M | N/A | N/A |
Financing | N/A | N/A | 15.79M | N/A | 18.26M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -26.47M | -20.48M | -23.75M | -24.87M | -19.81M |
Investing | -2.81M | 6.41M | -35.92M | 26.46M | 16.2M |
Financing | 23.96M | 15.8M | 55.66M | N/A | 15.79M |
Market Cap | 61.96M |
Price to Earnings Ratio | -3.94 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.58 |
Price to Book Ratio | 0.63 |
Dividend Yield | - |
Shares Outstanding | 21.67M |
Average Volume (1 week) | 67.63k |
Average Volume (1 Month) | 75.23k |
52 Week Change | 50.53% |
52 Week High | 7.42 |
52 Week Low | 1.61 |
Spread (Intraday) | 0.58 (19.08%) |
Company Name | Aileron Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aileronrx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.